10.9 C
New York
Saturday, April 20, 2024

Engineered extracellular vesicles-like biomimetic nanoparticles as an rising platform for focused most cancers remedy | Journal of Nanobiotechnology


  • Wei W, Zeng H, Zheng R, Zhang S, An L, Chen R, Wang S, Solar Okay, Matsuda T, Bray F, et al. Most cancers registration in China and its function in most cancers prevention and management. Lancet Oncol. 2020;21(7):e342–9.

    Article 
    PubMed 

    Google Scholar
     

  • Housman G, Byler S, Heerboth S, Lapinska Okay, Longacre M, Snyder N, Sarkar S. Drug resistance in most cancers: an outline. Cancers. 2014;6(3):1769–92.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an rising platform for most cancers remedy. Nat Nanotechnol. 2007;2(12):751–60.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, et al. Nano based mostly drug supply programs: current developments and future prospects. J Nanobiotechnol. 2018;16(1):71.

    Article 

    Google Scholar
     

  • Wilhelm S, Tavares AJ, Dai Q, Ohta S, Audet J, Dvorak HF, Chan WCW. Evaluation of nanoparticle supply to tumours. Nat Rev Mater. 2016;1(5):16014.

    Article 
    CAS 

    Google Scholar
     

  • Yong T, Wang D, Li X, Yan Y, Hu J, Gan L, Yang X. Extracellular vesicles for tumor focusing on supply based mostly on 5 options precept. J Management Launch. 2020;322:555–65.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, et al. Minimal info for research of extracellular vesicles 2018 (MISEV2018): a place assertion of the Worldwide Society for Extracellular Vesicles and replace of the MISEV2014 pointers. J Extracell Vesicles. 2018;7(1):1535750.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Montecalvo A, Shufesky WJ, Stolz DB, Sullivan MG, Wang Z, Divito SJ, Papworth GD, Watkins SC, Robbins PD, Larregina AT, et al. Exosomes as a short-range mechanism to unfold alloantigen between dendritic cells throughout T cell allorecognition. J Immunol. 2008;180(5):3081–90.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky AM, Breakefield XO. Glioblastoma microvesicles transport RNA and proteins that promote tumour development and supply diagnostic biomarkers. Nat Cell Biol. 2008;10(12):1470–6.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sarkar A, Mitra S, Mehta S, Raices R, Wewers MD. Monocyte derived microvesicles ship a cell dying message through encapsulated caspase-1. PLoS ONE. 2009;4(9):e7140.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tune S, Zhu L, Wang C, Yang Y. In vitro diagnostic applied sciences for the detection of extracellular vesicles: present standing and future instructions. VIEW. 2023;4(2):20220011.

    Article 

    Google Scholar
     

  • Valadi H, Ekström Okay, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated switch of mRNAs and microRNAs is a novel mechanism of genetic trade between cells. Nat Cell Biol. 2007;9(6):654–9.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Lewis JM, Vyas AD, Qiu Y, Messer KS, White R, Heller MJ. Built-in evaluation of exosomal protein biomarkers on alternating present electrokinetic chips allows fast detection of pancreatic most cancers in affected person blood. ACS Nano. 2018;12(4):3311–20.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Cavallaro S, Horak J, Hååg P, Gupta D, Stiller C, Sahu SS, Görgens A, Gatty HK, Viktorsson Okay, El Andaloussi S, et al. Label-free floor protein profiling of extracellular vesicles by an electrokinetic sensor. ACS Sens. 2019;4(5):1399–408.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Yan Z, Dutta S, Liu Z, Yu X, Mesgarzadeh N, Ji F, Bitan G, Xie YH. A label-free platform for identification of exosomes from completely different sources. ACS Sens. 2019;4(2):488–97.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhang L, He F, Gao L, Cong M, Solar J, Xu J, Wang Y, Hu Y, Asghar S, Hu L, et al. engineering exosome-like nanovesicles derived from asparagus cochinchinensis can inhibit the proliferation of hepatocellular carcinoma cells with higher security profile. Int J Nanomed. 2021;16:1575–86.

    Article 

    Google Scholar
     

  • Kandimalla R, Aqil F, Alhakeem SS, Jeyabalan J, Tyagi N, Agrawal A, Yan J, Spencer W, Bondada S, Gupta RC. Focused oral supply of paclitaxel utilizing colostrum-derived exosomes. Cancers. 2021;13(15):3700.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tan S, Wu T, Zhang D, Zhang Z. Cell or cell membrane-based drug supply programs. Theranostics. 2015;5(8):863–81.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Guo P, Busatto S, Huang J, Morad G, Moses MA. A facile magnetic extrusion methodology for getting ready endosome-derived vesicles for most cancers drug supply. Adv Funct Mater. 2021;31(44):2008326.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wan Y, Wang L, Zhu C, Zheng Q, Wang G, Tong J, Fang Y, Xia Y, Cheng G, He X, et al. Aptamer-conjugated extracellular nanovesicles for focused drug supply. Most cancers Res. 2018;78(3):798–808.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Gong YK, Winnik FM. Methods in biomimetic floor engineering of nanoparticles for biomedical purposes. Nanoscale. 2012;4(2):360–8.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kanwar SS, Dunlay CJ, Simeone DM, Nagrath S. Microfluidic gadget (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip. 2014;14(11):1891–900.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tian T, Zhu YL, Zhou YY, Liang GF, Wang YY, Hu FH, Xiao ZD. Exosome uptake by way of clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 supply. J Biol Chem. 2014;289(32):22258–67.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Xu B, Zhang Y, Du XF, Li J, Zi HX, Bu JW, Yan Y, Han H, Du JL. Neurons secrete miR-132-containing exosomes to manage mind vascular integrity. Cell Res. 2017;27(7):882–97.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cheng Q, Shi X, Han M, Smbatyan G, Lenz HJ, Zhang Y. Reprogramming exosomes as nanoscale controllers of mobile immunity. J Am Chem Soc. 2018;140(48):16413–7.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Liu H, Huang L, Mao M, Ding J, Wu G, Fan W, Yang T, Zhang M, Huang Y, Xie H-Y. Viral protein-pseudotyped and siRNA-electroporated extracellular vesicles for most cancers immunotherapy. Adv Func Mater. 2020;30(52):2006515.

    Article 
    CAS 

    Google Scholar
     

  • Cheng L, Zhang X, Tang J, Lv Q, Liu J. Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 sign for mixed photothermal remedy and most cancers immunotherapy. Biomaterials. 2021;275:120964.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Qing S, Lyu C, Zhu L, Pan C, Wang S, Li F, Wang J, Yue H, Gao X, Jia R, et al. Biomineralized bacterial outer membrane vesicles potentiate secure and environment friendly tumor microenvironment reprogramming for anticancer remedy. Adv Mater. 2020;32(47):2002085.

    Article 
    CAS 

    Google Scholar
     

  • Liu W, Li L, Jiang J, Wu M, Lin P. Purposes and challenges of CRISPR-Cas gene-editing to illness therapy in clinics. Summary Clin Med. 2021;4(3):179–91.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Xu Q, Zhang Z, Zhao L, Qin Y, Cai H, Geng Z, Zhu X, Zhang W, Zhang Y, Tan J, et al. Tropism-facilitated supply of CRISPR/Cas9 system with chimeric antigen receptor-extracellular vesicles towards B-cell malignancies. J Management Launch. 2020;326:455–67.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang Y, Cao Z, Wei Q, Ma Okay, Hu W, Huang Q, Su J, Li H, Zhang C, Fu X. VH298-loaded extracellular vesicles launched from gelatin methacryloyl hydrogel facilitate diabetic wound therapeutic by HIF-1α-mediated enhancement of angiogenesis. Acta Biomater. 2022;147:342–55.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Tune X, Xu L, Zhang W. Biomimetic synthesis and optimization of extracellular vesicles for bone regeneration. J Management Launch. 2023;355:18–41.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Xu M, Feng T, Liu B, Qiu F, Xu Y, Zhao Y, Zheng Y. Engineered exosomes: fascinating target-tracking traits for cerebrovascular and neurodegenerative illness therapies. Theranostics. 2021;11(18):8926–44.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Du J, Wan Z, Wang C, Lu F, Wei M, Wang D, Hao Q. Designer exosomes for focused and environment friendly ferroptosis induction in most cancers through chemo-photodynamic remedy. Theranostics. 2021;11(17):8185–96.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lv Q, Cheng L, Lu Y, Zhang X, Wang Y, Deng J, Zhou J, Liu B, Liu J. Thermosensitive exosome-liposome hybrid nanoparticle-mediated chemoimmunotherapy for improved therapy of metastatic peritoneal most cancers. Adv Sci. 2020;7(18):2000515.

    Article 
    CAS 

    Google Scholar
     

  • Bose RJ, Kumar US, Garcia-Marques F, Zeng Y, Habte F, McCarthy JR, Pitteri S, Massoud TF, Paulmurugan R. Engineered cell-derived vesicles displaying focusing on peptide and functionalized with nanocarriers for therapeutic microrna supply to triple-negative breast most cancers in mice. Adv Healthc Mater. 2022;11(5):e2101387.

    Article 
    PubMed 

    Google Scholar
     

  • Mahati S, Fu X, Ma X, Zhang H, Xiao L. Supply of miR-26a utilizing an exosomes-based nanosystem inhibited proliferation of hepatocellular carcinoma. Entrance Mol Biosci. 2021;8:738219.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shi X, Cheng Q, Hou T, Han M, Smbatyan G, Lang JE, Epstein AL, Lenz HJ, Zhang Y. Genetically engineered cell-derived nanoparticles for focused breast most cancers immunotherapy. Mol Ther. 2020;28(2):536–47.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang L, Zhou X, Zou W, Wu Y, Zhao J, Chen X, Zhou GG. Exosomes containing miRNAs focusing on HER2 synthesis and engineered to stick to HER2 on tumor cells floor exhibit enhanced antitumor exercise. J Nanobiotechnology. 2020;18(1):153.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang JH, Forterre AV, Zhao J, Frimannsson DO, Delcayre A, Antes TJ, Efron B, Jeffrey SS, Pegram MD, Matin AC. Anti-HER2 scFv-directed extracellular vesicle-mediated mRNA-based gene supply inhibits development of HER2-positive human breast tumor xenografts by prodrug activation. Mol Most cancers Ther. 2018;17(5):1133–42.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhang P, Zhang L, Qin Z, Hua S, Guo Z, Chu C, Lin H, Zhang Y, Li W, Zhang X, et al. Genetically engineered liposome-like nanovesicles as lively focused transport platform. Adv Mater. 2018;30(7):1705350.

    Article 

    Google Scholar
     

  • Gomari H, Forouzandeh Moghadam M, Soleimani M, Ghavami M, Khodashenas S. Focused supply of doxorubicin to HER2 constructive tumor fashions. Int J Nanomed. 2019;14:5679–90.

    Article 
    CAS 

    Google Scholar
     

  • Liang G, Zhu Y, Ali DJ, Tian T, Xu H, Si Okay, Solar B, Chen B, Xiao Z. Engineered exosomes for focused co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon most cancers. J Nanobiotechnology. 2020;18(1):10.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ma G, Severic M, Barker M, Pereira S, Ruiz A, Cheung CCL, Al-Jamal WT. Dually focused bioinspired nanovesicle delays superior prostate most cancers tumour development in vivo. Acta Biomater. 2021;134:559–75.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang Okay, Kumar US, Sadeghipour N, Massoud TF, Paulmurugan R. A microfluidics-based scalable strategy to generate extracellular vesicles with enhanced therapeutic microRNA loading for intranasal supply to mouse glioblastomas. ACS Nano. 2021;15(11):18327–46.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Xu S, Liu B, Fan J, Xue C, Lu Y, Li C, Cui D. Engineered mesenchymal stem cell-derived exosomes with excessive CXCR4 ranges for focused siRNA gene remedy towards most cancers. Nanoscale. 2022;14(11):4098–113.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kim G, Kim M, Lee Y, Byun JW, Hwang DW, Lee M. Systemic supply of microRNA-21 antisense oligonucleotides to the mind utilizing T7-peptide embellished exosomes. J Management Launch. 2020;317:273–81.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Han S, Li G, Jia M, Zhao Y, He C, Huang M, Jiang L, Wu M, Yang J, Ji X, et al. Supply of anti-miRNA-221 for colorectal carcinoma remedy utilizing modified twine blood mesenchymal stem cells-derived exosomes. Entrance Mol Biosci. 2021;8:743013.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shi Y, Lin G, Zheng H, Mu D, Chen H, Lu Z, He P, Zhang Y, Liu C, Lin Z, et al. Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition through reversing focal adhesion disassembly. J Nanobiotechnology. 2021;19(1):447.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jiang L, Gu Y, Du Y, Tang X, Wu X, Liu J. Engineering exosomes endowed with focused supply of triptolide for malignant melanoma remedy. ACS Appl Mater Interfaces. 2021;13(36):42411–28.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhuang M, Chen X, Du D, Shi J, Deng M, Lengthy Q, Yin X, Wang Y, Rao L. SPION embellished exosome supply of TNF-α to most cancers cell membranes by way of magnetism. Nanoscale. 2020;12(1):173–88.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Chen Y, Wang L, Zheng M, Zhu C, Wang G, Xia Y, Blumenthal EJ, Mao W, Wan Y. Engineered extracellular vesicles for concurrent Anti-PDL1 immunotherapy and chemotherapy. Bioact Mater. 2022;9:251–65.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Liu C, Liu X, Xiang X, Pang X, Chen S, Zhang Y, Ren E, Zhang L, Liu X, Lv P, et al. A nanovaccine for antigen self-presentation and immunosuppression reversal as a customized most cancers immunotherapy technique. Nat Nanotechnol. 2022;17(5):531–40.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang S, Huang W, Li Okay, Yao Y, Yang X, Bai H, Solar W, Liu C, Ma Y. Engineered outer membrane vesicle is potent to elicit HPV16E7-specific mobile immunity in a mouse mannequin of TC-1 graft tumor. Int J Nanomed. 2017;12:6813–25.

    Article 
    CAS 

    Google Scholar
     

  • Huang W, Shu C, Hua L, Zhao Y, Xie H, Qi J, Gao F, Gao R, Chen Y, Zhang Q, et al. Modified bacterial outer membrane vesicles induce autoantibodies for tumor remedy. Acta Biomater. 2020;108:300–12.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Huang L, Rong Y, Tang X, Yi Okay, Qi P, Hou J, Liu W, He Y, Gao X, Yuan C, et al. Engineered exosomes as an in situ DC-primed vaccine to spice up antitumor immunity in breast most cancers. Mol Most cancers. 2022;21(1):45.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Feng C, Xiong Z, Wang C, Xiao W, Xiao H, Xie Okay, Chen Okay, Liang H, Zhang X, Yang H. Folic acid-modified exosome-PH20 enhances the effectivity of remedy through modulation of the tumor microenvironment and straight inhibits tumor cell metastasis. Bioact Mater. 2021;6(4):963–74.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kamerkar S, Leng C, Burenkova O, Jang SC, McCoy C, Zhang Okay, Dooley Okay, Kasera S, Zi T, Sisó S, et al. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 results in potent monotherapy antitumor exercise. Sci Adv. 2022;8(7):eabj7002.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhou W, Xu M, Wang Z, Yang M. Engineered exosomes loaded with miR-449a selectively inhibit the expansion of homologous non-small cell lung most cancers. Most cancers Cell Int. 2021;21(1):485.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Blanco E, Shen H, Ferrari M. Rules of nanoparticle design for overcoming organic boundaries to drug supply. Nat Biotechnol. 2015;33(9):941–51.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • El-Boubbou Okay. Magnetic iron oxide nanoparticles as drug carriers: scientific relevance. Nanomedicine. 2018;13(8):953–71.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang J, Potocny AM, Rosenthal J, Day ES. Gold nanoshell-linear tetrapyrrole conjugates for close to infrared-activated twin photodynamic and photothermal therapies. ACS Omega. 2020;5(1):926–40.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bayda S, Hadla M, Palazzolo S, Riello P, Corona G, Toffoli G, Rizzolio F. Inorganic nanoparticles for most cancers remedy: a transition from lab to clinic. Curr Med Chem. 2018;25(34):4269–303.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Liu Y, Luo J, Chen X, Liu W, Chen T. Cell membrane coating know-how: a promising technique for biomedical purposes. Nanomicro Lett. 2019;11(1):100.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug supply. Nat Rev Drug Discov. 2021;20(2):101–24.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sedighi M, Sieber S, Rahimi F, Shahbazi MA, Rezayan AH, Huwyler J, Witzigmann D. Speedy optimization of liposome traits utilizing a mixed microfluidics and design-of-experiment strategy. Drug Deliv Transl Res. 2019;9(1):404–13.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Xiong F, Ling X, Chen X, Chen J, Tan J, Cao W, Ge L, Ma M, Wu J. Pursuing particular chemotherapy of orthotopic breast most cancers with lung metastasis from docking nanoparticles pushed by bioinspired exosomes. Nano Lett. 2019;19(5):3256–66.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhao L, Gu C, Gan Y, Shao L, Chen H, Zhu H. Exosome-mediated siRNA supply to suppress postoperative breast most cancers metastasis. J Management Launch. 2020;318:1–15.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Li M, Li S, Zhou H, Tang X, Wu Y, Jiang W, Tian Z, Zhou X, Yang X, Wang Y. Chemotaxis-driven supply of nano-pathogenoids for full eradication of tumors post-phototherapy. Nat Commun. 2020;11(1):1126.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhang D, Qin X, Wu T, Qiao Q, Tune Q, Zhang Z. Extracellular vesicles based mostly self-grown gold nanopopcorn for combinatorial chemo-photothermal remedy. Biomaterials. 2019;197:220–8.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bose RJC, Uday Kumar S, Zeng Y, Afjei R, Robinson E, Lau Okay, Bermudez A, Habte F, Pitteri SJ, Sinclair R, et al. Tumor cell-derived extracellular vesicle-coated nanocarriers: an environment friendly theranostic platform for the cancer-specific supply of anti-miR-21 and imaging brokers. ACS Nano. 2018;12(11):10817–32.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shen WT, Hsu RS, Fang JH, Hu PF, Chiang CS, Hu SH. Marginative delivery-mediated extracellular leakiness and T cell infiltration in lung metastasis by a biomimetic nanoraspberry. Nano Lett. 2021;21(3):1375–83.

    Article 
    PubMed 

    Google Scholar
     

  • Jia G, Han Y, An Y, Ding Y, He C, Wang X, Tang Q. NRP-1 focused and cargo-loaded exosomes facilitate simultaneous imaging and remedy of glioma in vitro and in vivo. Biomaterials. 2018;178:302–16.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang G, Hu W, Chen H, Shou X, Ye T, Xu Y. Cocktail technique based mostly on NK cell-derived exosomes and their biomimetic nanoparticles for twin tumor remedy. Cancers. 2019;11(10):1560.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen Q, Bai H, Wu W, Huang G, Li Y, Wu M, Tang G, Ping Y. Bioengineering bacterial vesicle-coated polymeric nanomedicine for enhanced most cancers immunotherapy and metastasis prevention. Nano Lett. 2020;20(1):11–21.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhupanyn P, Ewe A, Büch T, Malek A, Rademacher P, Müller C, Reinert A, Jaimes Y, Aigner A. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA supply in vitro and in vivo. J Management Launch. 2020;319:63–76.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Li S, Wu Y, Ding F, Yang J, Li J, Gao X, Zhang C, Feng J. Engineering macrophage-derived exosomes for focused chemotherapy of triple-negative breast most cancers. Nanoscale. 2020;12(19):10854–62.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang D, Yao Y, He J, Zhong X, Li B, Rao S, Yu H, He S, Feng X, Xu T, et al. Engineered cell-derived microparticles Bi(2)Se(3)/DOX@MPs for imaging guided synergistic photothermal/low-dose chemotherapy of most cancers. Adv Sci. 2020;7(3):1901293.

    Article 
    CAS 

    Google Scholar
     

  • Sancho-Albero M, Encinas-Giménez M, Sebastián V, Pérez E, Luján L, Santamaría J, Martin-Duque P. Switch of photothermal nanoparticles utilizing stem cell derived small extracellular vesicles for in vivo therapy of major and multinodular tumours. J Extracell Vesicles. 2022;11(3):e12193.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cao Y, Wu T, Zhang Okay, Meng X, Dai W, Wang D, Dong H, Zhang X. Engineered exosome-mediated near-infrared-II area V(2)C quantum dot supply for nucleus-target low-temperature photothermal remedy. ACS Nano. 2019;13(2):1499–510.

    CAS 
    PubMed 

    Google Scholar
     

  • Cheng G, Li W, Ha L, Han X, Hao S, Wan Y, Wang Z, Dong F, Zou X, Mao Y, et al. Self-assembly of extracellular vesicle-like metal-organic framework nanoparticles for cover and intracellular supply of biofunctional proteins. J Am Chem Soc. 2018;140(23):7282–91.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Tian R, Wang Z, Niu R, Wang H, Guan W, Chang J. tumor exosome mimicking nanoparticles for tumor combinatorial chemo-photothermal remedy. Entrance Bioeng Biotechnol. 2020;8:1010.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nie D, Dai Z, Li J, Yang Y, Xi Z, Wang J, Zhang W, Qian Okay, Guo S, Zhu C, et al. Most cancers-cell-membrane-coated nanoparticles with a yolk-shell construction increase most cancers chemotherapy. Nano Lett. 2020;20(2):936–46.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wu T, Liu Y, Cao Y, Liu Z. Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic remedy of glioblastoma. Adv Mater. 2022;34(15):e2110364.

    Article 
    PubMed 

    Google Scholar
     

  • Cao X, Tan T, Zhu D, Yu H, Liu Y, Zhou H, Jin Y, Xia Q. Paclitaxel-loaded macrophage membrane camouflaged albumin nanoparticles for focused most cancers remedy. Int J Nanomedicine. 2020;15:1915–28.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jiang Q, Liu Y, Guo R, Yao X, Sung S, Pang Z, Yang W. Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal remedy efficacy in tumors. Biomaterials. 2019;192:292–308.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ma Y, Zhang Y, Han R, Li Y, Zhai Y, Qian Z, Gu Y, Li S. A cascade synergetic technique induced by photothermal impact based mostly on platelet exosome nanoparticles for tumor remedy. Biomaterials. 2022;282:121384.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhou X, Miao Y, Wang Y, He S, Guo L, Mao J, Chen M, Yang Y, Zhang X, Gan Y. Tumour-derived extracellular vesicle membrane hybrid lipid nanovesicles improve siRNA supply by tumour-homing and intracellular freeway transportation. J Extracell Vesicles. 2022;11(3):e12198.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Deng L, Zhang H, Zhang Y, Luo S, Du Z, Lin Q, Zhang Z, Zhang L. An exosome-mimicking membrane hybrid nanoplatform for focused therapy towards Kras-mutant pancreatic carcinoma. Biomater Sci. 2021;9(16):5599–611.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Tan YN, Huang JD, Li YP, Li SS, Luo M, Luo J, Lee AW, Fu L, Hu FQ, Guan XY. Close to-infrared responsive membrane nanovesicles amplify homologous focusing on supply of anti-PD immunotherapy towards metastatic tumors. Adv Healthc Mater. 2022;11(6):e2101496.

    Article 
    PubMed 

    Google Scholar
     

  • Tian T, Liang R, Erel-Akbaba G, Saad L, Obeid PJ, Gao J, Chiocca EA, Weissleder R, Tannous BA. Immune checkpoint inhibition in GBM primed with radiation by engineered extracellular vesicles. ACS Nano. 2022;16(2):1940–53.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Guo L, Guo Y, Lau DHM, Xu YC. A novel particular small molecule peptide for non-small cell lung most cancers cell A549. Progress Biochem Biophys. 2007;34:1080–5.

    CAS 

    Google Scholar
     

  • Lin Q, Qu M, Zhou B, Patra HK, Solar Z, Luo Q, Yang W, Wu Y, Zhang Y, Li L, et al. Exosome-like nanoplatform modified with focusing on ligand improves anti-cancer and anti-inflammation results of imperialine. J Management Launch. 2019;311–312:104–16.

    Article 
    PubMed 

    Google Scholar
     

  • Nie W, Wu G, Zhang J, Huang LL, Ding J, Jiang A, Zhang Y, Liu Y, Li J, Pu Okay, et al. Responsive exosome nano-bioconjugates for synergistic most cancers remedy. Angew Chem Int Ed Engl. 2020;59(5):2018–22.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wu H, Zhu L, Torchilin VP. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug supply. Biomaterials. 2013;34(4):1213–22.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • de Guimarães MS, Cachumba JJM, Bueno CZ, Torres-Obreque KM, Lara GVR, Monteiro G, Barbosa LRS, Pessoa A Jr, Rangel-Yagui CO. Peg-grafted liposomes for l-asparaginase encapsulation. Pharmaceutics. 2022;14(9):1819.

    Article 

    Google Scholar
     

  • Zhuang J, Tan J, Wu C, Zhang J, Liu T, Fan C, Li J, Zhang Y. Extracellular vesicles engineered with valency-controlled DNA nanostructures ship CRISPR/Cas9 system for gene remedy. Nucleic Acids Res. 2020;48(16):8870–82.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhan Q, Yi Okay, Cui X, Li X, Yang S, Wang Q, Fang C, Tan Y, Li L, Xu C, et al. Blood exosomes-based focused supply of cPLA2 siRNA and metformin to modulate glioblastoma power metabolism for tailoring customized remedy. Neuro Oncol. 2022;24(11):1871–83.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Peng B, Nguyen TM, Jayasinghe MK, Gao C, Pham TT, Vu LT, Yeo EYM, Yap G, Wang L, Goh BC, et al. Sturdy supply of RIG-I agonists utilizing extracellular vesicles for anti-cancer immunotherapy. J Extracell Vesicles. 2022;11(4):e12187.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Pham TC, Jayasinghe MK, Pham TT, Yang Y, Wei L, Usman WM, Chen H, Pirisinu M, Gong J, Kim S, et al. Covalent conjugation of extracellular vesicles with peptides and nanobodies for focused therapeutic supply. J Extracell Vesicles. 2021;10(4):e12057.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Li R, Gong X, Hong C, Wang H, Chen Y, Tan Okay, Liu X, Wang F. An environment friendly photochemotherapy nanoplatform based mostly on the endogenous biosynthesis of photosensitizer in macrophage-derived extracellular vesicles. Biomaterials. 2021;279:121234.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zheng Z, Li Z, Xu C, Guo B, Guo P. Folate-displaying exosome mediated cytosolic supply of siRNA avoiding endosome trapping. J Management Launch. 2019;311–312:43–9.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kwon SH, Faruque HA, Kee H, Kim E, Park S. Exosome-based hybrid nanostructures for enhanced tumor focusing on and hyperthermia remedy. Colloids Surf B Biointerfaces. 2021;205:111915.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Nguyen Cao TG, Kang JH, You JY, Kang HC, Rhee WJ, Ko YT, Shim MS. Protected and focused sonodynamic most cancers remedy utilizing biocompatible exosome-based nanosonosensitizers. ACS Appl Mater Interfaces. 2021;13(22):25575–88.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Cheng H, Fan JH, Zhao LP, Fan GL, Zheng RR, Qiu XZ, Yu XY, Li SY, Zhang XZ. Chimeric peptide engineered exosomes for dual-stage gentle guided plasma membrane and nucleus focused photodynamic remedy. Biomaterials. 2019;211:14–24.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Cao H, Wang H, He X, Tan T, Hu H, Wang Z, Wang J, Li J, Zhang Z, Li Y. Bioengineered macrophages can responsively remodel into nanovesicles to focus on lung metastasis. Nano Lett. 2018;18(8):4762–70.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ye Z, Zhang T, He W, Jin H, Liu C, Yang Z, Ren J. Methotrexate-loaded extracellular vesicles functionalized with therapeutic and focused peptides for the therapy of glioblastoma multiforme. ACS Appl Mater Interfaces. 2018;10(15):12341–50.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Li L, He D, Guo Q, Zhang Z, Ru D, Wang L, Gong Okay, Liu F, Duan Y, Li H. Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian most cancers. J Nanobiotechnol. 2022;20(1):50.

    Article 
    CAS 

    Google Scholar
     

  • Zhou Q, Ding W, Qian Z, Zhu Q, Solar C, Yu Q, Tai Z, Xu Okay. Immunotherapy technique focusing on programmed cell dying ligand 1 and CD73 with macrophage-derived mimetic nanovesicles to deal with bladder most cancers. Mol Pharm. 2021;18(11):4015–28.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Forterre AV, Wang JH, Delcayre A, Kim Okay, Inexperienced C, Pegram MD, Jeffrey SS, Matin AC. Extracellular vesicle-mediated in vitro transcribed mRNA supply for therapy of HER2(+) breast most cancers xenografts in mice by prodrug CB1954 with out common toxicity. Mol Most cancers Ther. 2020;19(3):858–67.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Si Y, Guan J, Xu Y, Chen Okay, Kim S, Zhou L, Jaskula-Sztul R, Liu XM. Twin-targeted extracellular vesicles to facilitate mixed therapies for neuroendocrine most cancers therapy. Pharmaceutics. 2020;12(11):1079.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Fan M, Liu H, Yan H, Che R, Jin Y, Yang X, Zhou X, Yang H, Ge Okay, Liang XJ, et al. A CAR T-inspiring platform based mostly on antibody-engineered exosomes from antigen-feeding dendritic cells for exact stable tumor remedy. Biomaterials. 2022;282:121424.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Chen Okay, Si Y, Guan JS, Zhou Z, Kim S, Kim T, Shan L, Willey CD, Zhou L, Liu X. Focused extracellular vesicles delivered verrucarin A to deal with glioblastoma. Biomedicines. 2022;10(1):130.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jang Y, Kim H, Yoon S, Lee H, Hwang J, Jung J, Chang JH, Choi J, Kim H. Exosome-based photoacoustic imaging guided photodynamic and immunotherapy for the therapy of pancreatic most cancers. J Management Launch. 2021;330:293–304.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang X, Ding H, Li Z, Peng Y, Tan H, Wang C, Huang G, Li W, Ma G, Wei W. Exploration and functionalization of M1-macrophage extracellular vesicles for efficient accumulation in glioblastoma and powerful synergistic therapeutic results. Sign Transduct Goal Ther. 2022;7(1):74.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ding J, Lu G, Nie W, Huang LL, Zhang Y, Fan W, Wu G, Liu H, Xie HY. Self-activatable photo-extracellular vesicle for synergistic trimodal anticancer remedy. Adv Mater. 2021;33(7):e2005562.

    Article 
    PubMed 

    Google Scholar
     

  • Lara P, Huis In’t Veld RV, Jorquera-Cordero C, Chan AB, Ossendorp F, Cruz LJ. Zinc-phthalocyanine-loaded extracellular vesicles improve efficacy and selectivity of photodynamic remedy in co-culture and preclinical fashions of colon most cancers. Pharmaceutics. 2021;13(10):1547.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhan Q, Yi Okay, Qi H, Li S, Li X, Wang Q, Wang Y, Liu C, Qiu M, Yuan X, et al. Engineering blood exosomes for tumor-targeting environment friendly gene/chemo mixture remedy. Theranostics. 2020;10(17):7889–905.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Luo C, Hu X, Peng R, Huang H, Liu Q, Tan W. Biomimetic carriers based mostly on big membrane vesicles for focused drug supply and photodynamic/photothermal synergistic remedy. ACS Appl Mater Interfaces. 2019;11(47):43811–9.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang J, Chen P, Dong Y, Xie H, Wang Y, Soto F, Ma P, Feng X, Du W, Liu BF. Designer exosomes enabling tumor focused environment friendly chemo/gene/photothermal remedy. Biomaterials. 2021;276:121056.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhang J, Ji C, Zhang H, Shi H, Mao F, Qian H, Xu W, Wang D, Pan J, Fang X, et al. Engineered neutrophil-derived exosome-like vesicles for focused most cancers remedy. Sci Adv. 2022;8(2):eabj8207.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhou W, Zhou Y, Chen X, Ning T, Chen H, Guo Q, Zhang Y, Liu P, Zhang Y, Li C, et al. Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. Biomaterials. 2021;268:120546.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Belhadj Z, He B, Deng H, Tune S, Zhang H, Wang X, Dai W, Zhang Q. A mixed “eat me/don’t eat me” technique based mostly on extracellular vesicles for anticancer nanomedicine. J Extracell Vesicles. 2020;9(1):1806444.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ma C, He D, Tian P, Wang Y, He Y, Wu Q, Jia Z, Zhang X, Zhang P, Ying H, et al. miR-182 focusing on reprograms tumor-associated macrophages and limits breast most cancers development. Proc Natl Acad Sci USA. 2022;119(6):e2114006119.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Guo Q, Li X, Zhou W, Chu Y, Chen Q, Zhang Y, Li C, Chen H, Liu P, Zhao Z, et al. Sequentially triggered bacterial outer membrane vesicles for macrophage metabolism modulation and tumor metastasis suppression. ACS Nano. 2021;15(8):13826–38.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Lee H, Park H, Noh GJ, Lee ES. pH-responsive hyaluronate-anchored extracellular vesicles to advertise tumor-targeted drug supply. Carbohydr Polym. 2018;202:323–33.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Fan Z, Xiao Okay, Lin J, Liao Y, Huang X. Functionalized DNA allows programming exosomes/vesicles for tumor imaging and remedy. Small. 2019;15(47):e1903761.

    Article 
    PubMed 

    Google Scholar
     

  • Zhan Q, Yi Okay, Li X, Cui X, Yang E, Chen N, Yuan X, Zhao J, Hou X, Kang C. Phosphatidylcholine-engineered exosomes for enhanced tumor cell uptake and intracellular antitumor drug supply. Macromol Biosci. 2021;21(8):e2100042.

    Article 
    PubMed 

    Google Scholar
     

  • Pandita D, Kumar S, Lather V. Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and supply prospectives. Drug Discov At the moment. 2015;20(1):95–104.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Can A, Celikkan FT, Cinar O. Umbilical twine mesenchymal stromal cell transplantations: a systemic evaluation of scientific trials. Cytotherapy. 2017;19(12):1351–82.

    Article 
    PubMed 

    Google Scholar
     

  • Lorenzini B, Peltzer J, Goulinet S, Rival B, Lataillade JJ, Uzan G, Banzet S, Mauduit P. Producing vesicle-free cell tradition additive for human cells extracellular vesicles manufacturing. J Management Launch. 2023;355:501–14.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Görgens A, Corso G, Hagey DW, Jawad Wiklander R, Gustafsson MO, Felldin U, Lee Y, Bostancioglu RB, Sork H, Liang X, et al. Identification of storage situations stabilizing extracellular vesicles preparations. J Extracell Vesicles. 2022;11(6):e12238.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Grangier A, Branchu J, Volatron J, Piffoux M, Gazeau F, Wilhelm C, Silva AKA. Technological advances in direction of extracellular vesicles mass manufacturing. Adv Drug Deliv Rev. 2021;176:113843.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Related Articles

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Latest Articles